Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Cellino
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell and tissue replacement therapies. Cellino’s vision is to enable healthier lives worldwide with…
Cellino
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell and tissue replacement therapies. Cellino’s vision is to enable healthier lives worldwide with…
TL;DR
Headquarters: Cambridge, Massachusetts
Core product: Nebula™ AI-driven automated optical biomanufacturing platform for iPSC-derived therapies
Focus: Personalized regenerative cell, tissue, and organ replacements from patient iPSCs
Notable funding: $16M seed (2021); $80M Series A (2022); ARPA-H grant (2024)
Employee count: 133
Company Overview
Problem Domain
Scalable manufacturing bottleneck for personalized regenerative cell and tissue therapies derived from iPSCs.
Industry
Biotechnology Research
Funding Track Record
$16 million
$80 million
Awarded grant from Advanced Research Projects Agency for Health
Investor Signal
“Leaps by Bayer, Khosla Ventures, The Engine, Felicis, 8VC, Humboldt Fund”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week